Validation of cell density and viability assays using Cedex automated cell counter

Biologicals

Volumn 38, Issue 3, 2010, Pages 393-400

  Huang, Li Chun ^a,b   Lin, Wendy ^a   Yagami, Machiko ^a   Tseng, Daphne ^a   Miyashita Lin, Emily ^a   Singh, Nitasha ^a   Lin, Andy ^a   Shih, Shian Jiun ^a  

^a CELL GENESYS INC   (United States)

^b GENENTECH INC   (United States)

Author keywords

Analytical method validation; Cedex automatic cell counter; GVAX immunotherapy

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE;

ACCURACY; ANALYTIC METHOD; ANALYZER; ARTICLE; AUTOANALYSIS; CALIBRATION; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL LINE; CELL VIABILITY; COMPUTER PROGRAM; DILUTION; LYSIS; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ANALYSIS OF VARIANCE; CALIBRATION; CELL COUNT; CELL LINE, TUMOR; CELL SURVIVAL; CLINICAL LABORATORY TECHNIQUES; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 77952953261     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.01.009     Document Type: Article

References (10)

1. Gorenflo V.M., Smith L., Dedinsky B., Persson B., Piret J.M. Scale-up and optimization of an acoustic filter for 200L/day perfusion of a CHO cell culture. Biotechnol Bioeng 2002, 80:438-444.
2. Lutkemeyer D., Poggendorf I., Scherer T., Zhang J., Knoll A., Lehmann J. First steps in robot automation of sampling and sample management during cultivation of mammalian cells in pilot scale. Biotechnol Prog 2000, 16:822-828.
3. Ohashi R., Otero J.M., Chwistek A., Yamato I., Hamel J.F. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system. Biotechnol Prog 2002, 18:1292-1300.
4. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001, Appendix 3B.
5. Tennant J.R. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 1964, 2:685-694.
6. Gudermann F., Ziemeck P., Lehmann J. CeDeX: Ein integriertes Analysesystem zur optischen Zelldichtebestimmung. Bioscope 1996, 4:46-51.
7. Gudermann F., Ziemeck P., Lehmann J. Automated cell density determination. Animal cell technology from vaccines to genetic medicine 1997, 301-307. Kluwer Academic Publisher, Dordrecht.
8. Jomha N.M., Anoop P.C., Elliott J.A., Bagnall K., Mcgann L.E. Validation and reproducibility of computerised cell-viability analysis of tissue slices. BMC Musculoskelet Disord 2003, 4:5.
9. Higano C.S., Corman J.M., Smith D.C., Centeno A.S., Steidle C.P., Gittleman M., et al. Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer. Cancer 2008, 113:975-984.
10. Small E.J., Sacks N., Nemunaitis J., Urba W.J., Dula E., Centeno A.S., et al. Granulocyte macrophage colony-stimulating factor - secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer. Clin Cancer Res 2007, 13:3883-3891.